Invitae – $51 Million Follow-On

San Francisco – November 30, 2016 – Cooley advised the underwriters on Invitae Corporation’s $50.6 million follow-on offering of 8,433,332 shares of common stock, which included the full exercise of the underwriters’ option to purchase up to 1,099,999 additional shares of common stock.

JP Morgan acted as sole book-running manager for the offering and Cowen and Company acted as co-manager for the offering.

The mission of Invitae, which trades on The New York Stock Exchange under the symbol “NVTA,” is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.

Cooley advised the underwriters on Invitae’s $117 million IPO in February 2015.

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.